Eledon Pharmaceuticals, Inc. (NVUS) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Fortress Biotech, Inc.

Bolt Biotherapeutics, Inc.

Sol-Gel Technologies Ltd.

CASI Pharmaceuticals, Inc.

SELLAS Life Sciences Group, Inc.

Eledon Pharmaceuticals, Inc.

vTv Therapeutics, Inc.

NextCure, Inc.

Lantern Pharma, Inc.

Daré Bioscience, Inc.

Kineta, Inc.

Why is Eledon Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Eledon Pharmaceuticals, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Eledon Pharmaceuticals, Inc.

-18.64%

0.00

89.56%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-246.32%

EBIT to Interest (avg)

-39.90

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.09

Sales to Capital Employed (avg)

Tax Ratio

2.32%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

84.54%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.26

EV to EBIT

-1.30

EV to EBITDA

-1.30

EV to Capital Employed

-56.31

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-89.81%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

CASH AND EQV(HY)

Highest at USD 200.97 MM

NET PROFIT(Q)

At USD -18.02 MM has Grown at 57.1%

-2What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -67.24 MM

Here's what is working for Eledon Pharmaceuticals, Inc.

Net Profit

At USD -18.02 MM has Grown at 57.1%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Cash and Eqv

Highest at USD 200.97 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Eledon Pharmaceuticals, Inc.

Operating Cash Flow

Lowest at USD -67.24 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)